News & Insights
Gene therapy, ie the delivery of DNA or RNA into cells to treat disease, is at the cutting edge of medical research, and often makes the headlines More importantly, recent developments have… read more…
The European Patent Office (EPO) has issued updates for two cases being considered by the Enlarged Board of Appeal (EBA); G 2/19 and G 1/18 In the Autumn of 2017, the EPO’s Boards of Appeal moved… read more…
Amid changing technology trends, more rare earth metals are required to meet our needs – and patent protection may be one solution In this article for Managing Intellectual Property, Mathys &… read more…
This Saturday, 20 July 2019, marks 50 years since Neil Armstrong first stepped on the moon, and inspired millions around the world to enter careers in science and engineering In the intervening… read more…
We are delighted to share the new Mathys & Squire logo and brand Since Mathys & Squire was founded in 1910, the firm has grown and changed shape in many ways From the move of our London… read more…
Mathys & Squire has featured in the Financial Times’ report of ‘Europe’s Leading Patent Law Firms 2019’ 2,727 clients and peers participated in the survey, with several thousand… read more…
In this article for Managing Intellectual Property, Mathys & Squire Associate Alex Robinson provides expert commentary on whether the revised rules of procedure at the EPO’s Boards of Appeal are… read more…
IP rights are valuable business assets and can be an important source of financing Virtually everything your business creates, that sets it apart from your competitors, is likely to attract some… read more…
All roads lead to Rome, all Silk Roads lead to China With the latest, most ambitious Chinese initiative dawning upon us, it is essential for IP right holders to factor in the changes and challenges… read more…
Mathys & Squire uses cookies
We use cookies to ensure you get the best experience on our website. More details are available via our Cookie Policy.